WSFS
NBIX icon

Wilmington Savings Fund Society’s Neurocrine Biosciences NBIX Stock Holding History

Wilmington Savings Fund Society’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$674 Buy
+4
New +$593 ﹤0.01% 1420
2025
Q3 		– Sell
-88
Closed -$11.1K – 1813
2025
Q2 		$11.1K Sell
88
-39
-31% -$4.47K ﹤0.01% 1609
2025
Q1 		$14K Sell
127
-3,549
-97% -$450K ﹤0.01% 1556
2024
Q4 		$502K Buy
3,676
+343
+10% +$42.4K 0.01% 587
2024
Q3 		$384K Buy
+3,333
New +$457K 0.01% 640

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Wilmington Savings Fund Society's NBIX Position: Q2 2026 in Review

Wilmington Savings Fund Society opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 4 shares worth $674. The stake represents ﹤0.01% of the portfolio and ranks #1420 among its holdings. This is a return to the name: Wilmington Savings Fund Society previously reported a position in NBIX as recently as Q2 2025.

Wilmington Savings Fund Society first reported a position in NBIX in Q3 2024 and has held it in 5 quarters since. The position peaked at $502K in Q4 2024. 302 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Wilmington Savings Fund Society held 4 shares of Neurocrine Biosciences worth $674 as of Q2 2026.
  • Neurocrine Biosciences was a new Wilmington Savings Fund Society position in Q2 2026.
  • Neurocrine Biosciences made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1420 holding.
  • Wilmington Savings Fund Society first reported a position in Neurocrine Biosciences in Q3 2024 and has held it in 5 quarters since.
  • Wilmington Savings Fund Society's Neurocrine Biosciences position peaked at $502K in Q4 2024.
  • 302 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.